10-Q: ReposiTrak Reports 16% Revenue Increase in Q3 2025, Driven by Traceability and Compliance Solutions
Quarterly Report
ReposiTrak, Inc. announces a 16% year-over-year revenue increase for the third quarter of 2025, fueled by growth in its compliance, supply chain, and traceability solutions.
Summary
- ReposiTrak, Inc. reported a 16% increase in revenue for the three months ended March 31, 2025, reaching $5,913,732 compared to $5,084,866 in the same period of 2024.
- The revenue growth was attributed to increased recurring subscription revenue across all business lines, including compliance, supply chain, and traceability.
- Cost of services and product support increased by 10% to $911,693, primarily due to investments in development personnel to automate onboarding and support services for the FSMA 204 initiative.
- Sales and marketing expenses rose by 4% to $1,408,861, driven by higher sales commissions, travel, and marketing investments.
- General and administrative expenses increased by 8% to $1,455,602, mainly due to higher employee benefit costs and insurance expenses.
- Net income applicable to common shareholders was $1,880,063, or $0.10 per share, compared to $1,416,082, or $0.08 per share, in the prior year.
- For the nine months ended March 31, 2025, revenue increased by 10% to $16,845,782 compared to $15,270,729 in the same period of 2024.
- Net cash provided by operating activities for the nine months ended March 31, 2025, was $6,763,371, compared to $4,910,741 for the same period in 2024.
- The company redeemed 210,279 shares of Series B Preferred Stock for $2,249,985 during the nine months ended March 31, 2025.
- As of March 31, 2025, $7,892,190 remained available for share repurchases under the company's share repurchase program.
Sentiment
Score: 8
Explanation: The document presents a positive outlook with strong revenue growth, increased profitability, and a focus on a growing market segment (traceability). The company's strong cash position and strategic investments further contribute to the positive sentiment.
Positives
- Strong revenue growth of 16% in Q3 2025 indicates increasing demand for ReposiTrak's services.
- Recurring subscription revenue is driving growth, providing a stable and predictable revenue stream.
- Increased net income applicable to common shareholders demonstrates improved profitability.
- Investments in automation and offshore resources are expected to improve efficiency and support scalability.
- The company's focus on traceability positions it well to capitalize on regulatory changes and industry trends.
- The company has a strong cash position with $28,134,321 in cash and cash equivalents as of March 31, 2025.
- The company is actively redeeming preferred stock, reducing dividend obligations.
Negatives
- Increased costs of services and product support, sales and marketing, and general and administrative expenses may impact profitability if not managed effectively.
- The company's reliance on interest income may be affected by the Federal Reserve's interest rate cuts.
- The company's future success depends on the continuing market acceptance of its products and services.
Risks
- Macroeconomic conditions could impact the company's revenue growth and profitability.
- The timing and extent of spending required for research and development efforts could affect the company's financial performance.
- Changes in regulatory requirements or industry standards could require the company to make significant investments in its products and services.
- The company's ability to maintain its competitive advantage in the market is subject to various factors, including the emergence of new competitors and technologies.
Future Outlook
The company believes that its existing cash and short-term investments, together with funds generated from operations, are sufficient to fund operating and investment requirements for at least the next twelve months.
Management Comments
- Growth in traceability is the result of growing industry and consumer response to food contaminations and food safety hazards, whether biological, chemical, physical, or allergenic.
- As more and more retailers, wholesalers and distributors mandate their requirements to suppliers, the Company continues to see a corresponding rise in demand for its services.
- We continue to focus our sales efforts on marketing our software services on a recurring subscription basis and placing less emphasis on transactional revenue.
- We believe the uptick in marketing spending will flatten over the next twelve months as awareness of the traceability regulatory deadline approaches and the industry continues to mandate early adoption.
Industry Context
The report highlights the increasing importance of traceability in the food industry, driven by regulatory requirements like FSMA 204 and retailer mandates. ReposiTrak is positioning itself as a key player in this space by offering a low-cost, easy-to-deploy traceability solution.
Comparison to Industry Standards
- While the document does not provide specific comparisons to industry standards, the focus on FSMA 204 compliance and traceability aligns with the broader industry trend towards enhanced food safety and supply chain visibility.
- Comparable companies in the SaaS-based supply chain management and compliance space include companies like TraceGains, FoodLogiQ, and SafetyChain Software.
- These companies also offer solutions for food safety compliance, traceability, and supply chain management, and compete with ReposiTrak for market share.
- The success of ReposiTrak will depend on its ability to differentiate its offerings and effectively market its solutions to retailers, wholesalers, and suppliers.
Related Party Transactions
- During the nine months ended March 31, 2025, the Company continued to be a party to a service agreement (the Service Agreement) with Fields Management, Inc. (FMI), pursuant to which FMI provided certain executive management services to the Company, including designating Randall K. Fields to perform the functions of President and Chief Executive Officer for the Company.
- During the nine months ended March 31, 2025 and 2024, the Company paid FMI $769,213 and $727,353, respectively, in connection with the Service Agreement.
Stakeholder Impact
- Shareholders will benefit from the company's strong financial performance and the continued redemption of preferred stock.
- Employees will benefit from the company's growth and investments in automation and offshore resources.
- Customers will benefit from the company's focus on providing low-cost, easy-to-deploy traceability solutions.
- The company's focus on food safety and traceability will contribute to a safer food supply chain for consumers.
Next Steps
- Continue to focus sales efforts on marketing software services on a recurring subscription basis.
- Continue to invest in automation and offshore resources to support the FSMA 204 traceability initiative.
- Continue to redeem and retire the company's Series B Convertible Preferred Stock.
- Monitor and adapt to changes in regulatory requirements and industry standards.
Key Dates
| Date | Description |
|---|---|
| 2011 | Food Safety Modernization Act of 2011 (FSMA) |
| 2020 | United States Food & Drug Administration (FDA) announced the New Era of Smarter Food Safety blueprint. |
| 2022-11 | FDA announced the final rule on the Food Safety Modernization Act Section 204(d) (FSMA 204) Traceability for High-Risk Foods. |
| 2023-01-20 | The rule became effective and applies to any person or Company that manufactures, processes, packs or hold foods the FDA considers to be high risk for food borne illness, the so-called Food Traceability List (FTL). |
| 2023-08-29 | The Board approved the redemption and retirement of its Series B Preferred and Series B-1 Preferred for their stated value, or $10.70 for each share of Preferred Stock, resulting in an aggregate purchase price of $8,964,214 (the Preferred Redemption). |
| 2023-12-21 | The Company effected a change of its corporate name from Park City Group, Inc. to ReposiTrak, Inc. |
| 2025-03-21 | The Company's Board of Directors declared a quarterly cash dividend of $0.01815 per share ($0.0726 per year), payable to shareholders of record on March 31, 2025, which were paid to shareholders of record on or about May 15, 2025. |
| 2025-03 | The deadline for compliance with FSMA 204 was extended by 30 months to July 20, 2028. |
| 2025-03-31 | End of the quarterly period. |
| 2025-05-15 | Date of the report. |
Keywords
ReposiTrak, traceability, FSMA 204, compliance, supply chain, revenue, SaaS, food safety, preferred stock, share repurchase
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.